Investigación
Educación
Soluciones
Iniciar sesión
ES
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Timm Baumeister has not added Biography.
If you are Timm Baumeister and would like to personalize this page please email our Author Liaison for assistance.
Structure-based identification of ureas as novel nicotinamide phosphoribosyltransferase (Nampt) inhibitors.
Journal of medicinal chemistry Jun, 2013 | Pubmed ID: 23617784
Discovery of potent and efficacious urea-containing nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with reduced CYP2C9 inhibition properties.
Bioorganic & medicinal chemistry letters Jun, 2013 | Pubmed ID: 23668988
Structure-based discovery of novel amide-containing nicotinamide phosphoribosyltransferase (nampt) inhibitors.
Journal of medicinal chemistry Aug, 2013 | Pubmed ID: 23859118
Identification of 2,3-dihydro-1H-pyrrolo[3,4-c]pyridine-derived ureas as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT).
Bioorganic & medicinal chemistry letters Sep, 2013 | Pubmed ID: 23899614
Identification of amides derived from 1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT).
Bioorganic & medicinal chemistry letters Oct, 2013 | Pubmed ID: 24021463
Discovery of potent and efficacious cyanoguanidine-containing nicotinamide phosphoribosyltransferase (Nampt) inhibitors.
Bioorganic & medicinal chemistry letters Jan, 2014 | Pubmed ID: 24279990
Fragment-based identification of amides derived from trans-2-(pyridin-3-yl)cyclopropanecarboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT).
Journal of medicinal chemistry Feb, 2014 | Pubmed ID: 24405419
Fragment-based design of 3-aminopyridine-derived amides as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT).
Bioorganic & medicinal chemistry letters Feb, 2014 | Pubmed ID: 24433859
Identification of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with no evidence of CYP3A4 time-dependent inhibition and improved aqueous solubility.
Bioorganic & medicinal chemistry letters Feb, 2015 | Pubmed ID: 25556090
H3 Biomedicine
Manav Korpal1,
Jacob Feala1,
Xiaoling Puyang1,
Jian Zou1,
Alex H. Ramos2,
Jeremy Wu1,
Timm Baumeister1,
Lihua Yu1,
Markus Warmuth1,
Ping Zhu1
1, H3 Biomedicine,
2, Massachusetts General Hospital
Privacidad
Condiciones de uso
Políticas
Contáctenos
RECOMIENDE A LA BIBLIOTECA
BOLETINES de JoVE
JoVE Journal
Colecciones de métodos
JoVE Encyclopedia of Experiments
Archivo
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centro de recursos académicos
Autores
Bibliotecarios
Acceso
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados